Gene Therapy in Bone Regeneration: A Summary of Delivery Approaches for Effective Therapies - Intracellular Delivery: Fundamentals and Applications - page 840

Govender S, Csimma C, Genant HK, Valentin-Opran A. Recombinant human bone morphogenetic
protein-2 for treatment of open tibial fractures . J Bone Joint Surg Am 2002;84(12):
2123-2134.
Grandi P, Wang S, Schuback D, Krasnykh V, Spear M, Curiel D, et al. HSV-1 virions engineered
for specific binding to cell surface receptors . Molecular Therapy. 2004;9(3):419-27.
Grandi P, Fernandez J, Szentirmai O, Carter R. Targeting HSV-1 virions for specific binding to
epidermal growth factor receptor-vIII-bearing tumor cells . Cancer Gene. 2010;17:655-663.
Grieger J, Samulski R. Packaging capacity of adeno-associated virus serotypes: Impact of larger
genomes on infectivity and postentry steps . J Virol. 2005;79(15):9933.
Hagstrom J, Ludtke J, Bassik M, Sebestyen M, Adam S, Wolff J. Nuclear import of DNA in dig-
itonin-permeabilized cells . J Cell Sci 1997;110:2323-2331.
Heckman JD, Ryaby JB, McCabe J, Frey JJ, Kilcoyne RF. Acceleration of tibial fracture - healing
by non-invasive, low-intensity pulsed ultrasound. J. Bone Joint Surg. 1994;76: 26-34.
Harbison C, Chiorini J, Parrish C. The parvovirus capsid odyssey: from the cell surface to the
nucleus. Trends in Microbiology. 2008;16(5):208-214.
Harrison S. Mechanism of membrane fusion by viral envelope proteins . Adv Virus Res.
2005;64:231-261.
Harui A, Suzuki S, Kochanek S, Mitani K. Frequency and stability of chromosomal integration of
adenovirus vectors . J Virol. 1999;73(7):6141.
Haynes C, Erlwein O, Schnierle BS. Modified envelope glycoproteins to retarget retroviral vec-
tors . Curr Gene Ther. 2003;3(5):405-10.
Hedley S, Maur Ad, Hohn S, Escher D, Barberis A. An adenovirus vector with a chimeric fiber
incorporating stabilized single chain antibody achieves targeted gene delivery. Gene Ther.
2005;13:88-94.
Helm G, Alden T, Beres E, Hudson S, Das S, Engh J, Pittman D, Kern K, Kallmes D. Use of bone
morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg
2000;92(2 S):191-6.
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sat S, Sanjo H, Matsumoto M, Hoshino K, Wagner H,
Takeda K, Akira S. A Toll-like receptor recognizes bacterial DNA . Nature 2000;408: 740-745.
Hoekstra D, Rejman J, Wasungu L, Shi F, Zuhorn I. Gene delivery by cationic lipids: in and out
of an endosome . Biochem Soc Trans 2007;35(1):68-71.
Hong KS, Kim EC, Bang SH, Chung CH, Lee YI, Hyun JK, Lee HH, Jang JH, Kim TI, Kim HW.
Bone regeneration by bioactive hybrid membrance containing FGF2 within rat calvarium . J
Biomed Mat Res 2010; 94A(4):1187-1194.
Howarth J, Lee Y, Uney J. Using viral vectors as gene transfer tools (cell biology and toxicology
special issue: ETCS-UK 1 day meeting on genetic manipulation of cells). Cell Biol Toxicol.
2010;26(1):1-20.
Hsu C, Hendzel M, Uludag H. Improved transfection efficiency of an aliphatic lipid substituted
2 kDa polyethylenimine is attributed to enhanced nuclear association and uptake in rat bone
marrow stromal cells. J Gene Med 2010, in press.
Hu W, Wang Z, Hollister S, Krebsbach P. Localized viral vector delivery to enhance in situ regen-
erative gene therapy . Gene Ther 2007;12(11):891-901.
Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ. Bone regeneration in a rat cranial
defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic pro-
tein-4 (BMP-4). Gene Therapy 2005; 12:418.
Incani V, Lin X, Lavansanifar A, Uludag H. Relationship between the extent of lipid substitution on
poly(L-lysine) and the DNA delivery efficiency . ACS Appl Mater Interfaces 2009;1(4):841-8.
Ishihara A, Shields K, Litsky A, Mattoon J, Weisbrode S, Bartlett J, Bertone A. Osteogenic gene
regulation and relative acceleration of healing by adenoviral-mediated transfer of human
BMP-2 or −6 in equine osteotomy and ostectomy models . J Orthop Res 2008;26(6):764-71.
Ishihara A, Zekas L, Weisbrode S, Bertone A. Comparative efficacy of dermal fibroblast-mediated
and direct adenoviral bone morphogenetic protein-2 gene therapy for bone regeneration in an
equine rib model . Gene Ther 2010;17(6):733-44.